Skip to main content

Table 3 Factors associated with vaccine breakthrough by multivariate analysis

From: Clinical features and severe outcome predictors of COVID-19 vaccine breakthrough infection among hospitalized patients: results from Egypt severe acute respiratory infections sentinel surveillance, 2021–2022

 

OR

95% CI

P value

Inactivated vaccines

96.37

54.70-169.77

< 0.001

Age 16–35

3.44

1.75–6.76

< 0.001

Male gender

2.27

1.42–3.65

< 0.001

Cardiovascular disease

2.16

1.21–3.85

0.009

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us